In regard to the observed progressivity of the hearing impairment in clarinet mice (Dunbar et al. 2019), the earliest reported clinical diagnosis of hearing loss of the CLRN2 affected individuals in the family we present is between 2 and 3 years of age. This evidence concerns the gene CLRN2 and hearing loss disorder.